Federal Register / Vol. 65, No. 81 / Wednesday, April 26, 2000 / Notices 24491

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the meeting of the

National Cancer Advisory Board.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

A portion of the meeting will be

closed to the public in accordance with

the provisions set forth in sections

552b(c)(6) and 552b(c)(9)(B), Title 5

U.S.C., as amended. The discussions

could disclose confidential trade secrets

or commercial property such as

patentable material, and personal

information concerning individuals

associated with the review of

applications, and information

concerning NCI and/or its contractors,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy, and the

premature disclosure of discussions

related to personnel and programmatic

issues would be likely to significantly

frustrate the subsequent implementation

of recommendations.

Name of Committee: National Cancer

Advisory Board and Subcommittee on Cancer

Centers.

Dates: June 12–14, 2000.

Name of Committee: Subcommittee on

Cancer Centers.

Open: June 12, 7:00 p.m. to Recess.

Agenda: Cancer Centers Support Guideline

Update.

Place: Bethesda Hyatt Regency, One

Bethesda Metro Center, Bethesda, MD 20814,

(301) 657–1234.

Contact Person: Dr. Brian Kimes, Executive

Secretary, Office of Centers, Training, and

Resources, National Cancer Institute,

National Institutes of Health, 6116 Executive

Boulevard, Suite 700, Bethesda, MD 20892,

(301) 496–8537.

Name of Committee: National Cancer

Advisory Board.

Open: June 13, 8:45 a.m. to 3:45 p.m. and

June 14, 9:00 a.m. to 3:00 p.m.

Agenda: Program reports and

presentations; Business of the Board. For

detailed agenda: See NCI Homepage/

Advisory Board and Groups, http://

deainfo.nci.nik.gov/ADVISORY/boards.htm.

Tentative agenda available 10 working days

prior to meetings; Final agenda available 5

working days prior to meetings.

Closed: June 13, 2000, 4:00 p.m. to Recess.

Agenda: Review of Grant Applications.

Place: Building 31, C Wing, 6 Floor,

Conference Room 10, National Institutes of

Health, 9000 Rockville Pike, Bethesda, MD

20892.

Contact Person: Dr. Marvin R. Kalt,

Executive Secretary, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, 8th Floor, Room 8022,

Bethesda, MD 20892–8327, (301) 496–5147.

(Catalogue of Federal Domestic Assistance

Program Nos. 92.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394; Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: April 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10413 Filed 4–25–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Eye Institute; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

National Advisory Eye Council.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in section 552b(c)(4)

and 552b(c)(6), Title 5 U.S.C., as

amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Advisory

Eye Council.

Date: June 8, 2000.

Open: 8:30 a.m. to 11:30 a.m.

Agenda: Following opening remarks by the

Director, NEI, there will be presentations by

the staff of the institute and discussions

concerning institute programs and policies.

Place: 6130 Executive Boulevard, Room G,

Rockville, MD 20852.

Closed: 11:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: 6130 Executive Boulevard, Room G,

Rockville, MD 20852.

Contact Person: Lois DeNinno, National

Eye Institute, Executive Plaza South, Suite

350, 6120 Executive Blvd., MSC 7167,

Bethesda, MD 20892, 301–496–9110.

(Catalogue of Federal Domestic Assistance

Program NOs. 93.867, Vision Research,

National Institutes of Health, HHS)

Dated: April 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10409 Filed 4–25–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel

Family Study of Nasopharyngeal Carcinoma

and Oral Cancer.

Date: May 17, 2000.

Time: 2:30 p.m. to 3:30 p.m.

Agenda: To review and evaluate contract

proposals.

Place: NIH, Rockledge II, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: C. James Scheirer, Chief,

Review Branch, DEA, NIH, NHLBI,

Rockledge Center II, 6701 Rockledge Drive,

Suite 7216, Bethesda, MD 20892–7924, (301)

435–0206.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel,

Biology of Hematopoietic Stem Cells RFA.

Date: June 7–8, 2000.

Time: 7 a.m. 3 p.m.

Agenda: To review and evaluate grant

applications.

24492 Federal Register / Vol. 65, No. 81 / Wednesday, April 26, 2000 / Notices

Place: Columbia Sheraton, 10207

Wincopin Circle, Columbia, MD 21044.

Contact Person: Terry Rogers Bishop,

Scientific Review Administrator, Review

Branch, NIH, NHLBI, DEA, Rockledge Center

II, 6701 Rockledge Drive, Suite 7210,

Bethesda, MD 20892–7924, (301) 435–0303.

(Catalog of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resource Research, National Institutes of

Health, HHS)

Dated: April 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10405 Filed 4–25–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel,

Sibling Donor Cord Blood Banking and

Transplantation.

Date: May 9, 2000.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge II, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Robert B. Moore, Scientific

Review Administrator, National Heart, Lung,

and Blood Institute, Rockledge Building II,

Suite 7192, MSC 7924, 6701 Rockledge Drive,

Bethesda, MD 20892, 301/435–3541.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: April 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10406 Filed 4–25–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Board of Scientific Counselors, NHLBI.

The meeting will be closed to the

public as indicated below in accordance

with the provisions set forth in section

552b(c)(6), Title 5 U.S.C., as amended

for the review, discussion, and

evaluation of individual intramural

programs and projects conducted by the

National Heart, Lung, and Blood

Institute, including consideration of

personnel qualifications and

performance, and the competence of

individual investigators, the disclosure

of which would constitute a clearly

unwarranted invasion of personal

privacy.

Name of Committee: Board of Scientific

Counselors, NHLBI.

Date: June 1–2,2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: Marriott Hotel, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Elizabeth G. Nabel,

Scientific Director for Clinical Research,

National Heart, Lung, and Blood Institute,

Division of Intramural Research, Building 10,

Room 8C103, MSC 1754, Bethesda, MD

20892, 301/496–1518.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: April 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10407 Filed 4–25–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Alcohol Abuse

and Alcoholism; Notice of Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Board of Scientific Counselors, NIAAA.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public as indicated below in accordance

with the provisions set forth in section

552b(c)(6), Title 5 U.S.C., as amended

for the review, discussion, and

evaluation of individual intramural

programs and projects conducted by the

National Institute on Alcohol Abuse and

Alcoholism, including consideration of

personnel qualifications and

performance, and the competence of

individual investigators, the disclosure

of which would constitute a clearly

unwarranted invasion of personal

privacy.

Name of Committee: Board of Scientific

Counselors, NIAAA.

Date: June 1–2, 2000.

Open: June 1, 2000, 8:30 a.m. to 9 a.m.

Agenda: To discuss administrative details.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Closed: June 1, 2000, 9 a.m. to 11 a.m.

Agenda: To review and evaluate the

laboratory of neurogenetics.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Benedict J. Latteri, Acting

Deputy Director, Division of Intramural

Clinical and Biological Research, National

Institute on Alcohol Abuse and Alcoholism,

9000 Rockville Pike, Room 1B58, Building

31—MSC 2088, Bethesda, MD 20892–2088,

301–402–1227.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.271, Alcohol Research

Career Development Awards for Scientists

and Clinicians; 93.272, Alcohol National

Research Service Awards for Research

Training; 93.273, Alcohol Research Programs;

93.891, Alcohol Research Center Grants,

National Institutes of Health, HHS)

Dated: April 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10408 Filed 4–25–00; 8:45 am]

BILLING CODE 4140–01–M